Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK7 | P49862 | 8/20 | 0.42 |
| ▸ | KLK5 | Q9Y337 | 6/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9983610 | 1.00 | KLK7 (0.42) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL12024363 | 0.93 | KLK7 (0.41) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL12024362 | 0.93 | KLK7 (0.41) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL9984909 | 0.89 | KLK7 (0.43) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL16510409 | 0.89 | KLK7 (0.43) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL1976602 | 0.86 | PPARA (0.42) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL13053335 | 0.86 | PPARA (0.42) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL12023829 | 0.84 | KLK7 (0.42) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL16510414 | 0.84 | KLK7 (0.42) | KLK7KLK5PPARAKMT2AL3MBTL1 | |
| SCHEMBL1219509 | 0.84 | KMT2A (0.43) | KLK7KLK5PPARAKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2392568-A1 | Heterocyclic amino acids for prostate cancer imaging | Bayer Pharma Aktiengesellschaft (DE) | 2011-12-07 | — | — | EP | disclosed |